Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline

Katia Hardies, Yiying Cai, Claude Jardel, Anna C. Jansen, Mian Cao, Patrick May, Tania Djémié, Caroline Hachon Le Camus, Kathelijn Keymolen, Tine Deconinck, Vikas Bhambhani, Catherine Long, Samin A. Sajan, Katherine L. Helbig, Arvid Suls, Rudi Balling, Ingo Helbig, Peter De Jonghe, Christel Depienne, Pietro De Camilli & 3 others Sarah Weckhuysen, Federico Zara, Pasquale Striano

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

SYNJ1 encodes a polyphosphoinositide phosphatase, synaptojanin 1, which contains two consecutive phosphatase domains and plays a prominent role in synaptic vesicle dynamics. Autosomal recessive inherited variants in SYNJ1 have previously been associated with two different neurological diseases: a recurrent homozygous missense variant (p.Arg258Gln) that abolishes Sac1 phosphatase activity was identified in three independent families with early onset parkinsonism, whereas a homozygous nonsense variant (p.Arg136∗) causing a severe decrease of mRNA transcript was found in a single patient with intractable epilepsy and tau pathology. We performed whole exome or genome sequencing in three independent sib pairs with early onset refractory seizures and progressive neurological decline, and identified novel segregating recessive SYNJ1 defects. A homozygous missense variant resulting in an amino acid substitution (p.Tyr888Cys) was found to impair, but not abolish, the dual phosphatase activity of SYNJ1, whereas three premature stop variants (homozygote p.Trp843∗ and compound heterozygote p.Gln647Argfs∗6/p.Ser1122Thrfs∗3) almost completely abolished mRNA transcript production. A genetic follow-up screening in a large cohort of 543 patients with a wide phenotypical range of epilepsies and intellectual disability revealed no additional pathogenic variants, showing that SYNJ1 deficiency is rare and probably linked to a specific phenotype. While variants leading to early onset parkinsonism selectively abolish Sac1 function, our results provide evidence that a critical reduction of the dual phosphatase activity of SYNJ1 underlies a severe disorder with neonatal refractory epilepsy and a neurodegenerative disease course. These findings further expand the clinical spectrum of synaptic dysregulation in patients with severe epilepsy, and emphasize the importance of this biological pathway in seizure pathophysiology.

Original languageEnglish
Pages (from-to)2420-2430
Number of pages11
JournalBrain
Volume139
Issue number9
DOIs
Publication statusPublished - Sep 1 2016

Fingerprint

Phosphoric Monoester Hydrolases
Seizures
Epilepsy
Parkinsonian Disorders
Exome
Messenger RNA
Synaptic Vesicles
Homozygote
Amino Acid Substitution
Heterozygote
Intellectual Disability
Neurodegenerative Diseases
Genome
Pathology
Phenotype
Onset

Keywords

  • early onset epilepsy
  • neurodegenerative disorder
  • recessive disorder
  • SYNJ1
  • SYNJ1 dual phosphatase activity

ASJC Scopus subject areas

  • Medicine(all)
  • Arts and Humanities (miscellaneous)
  • Clinical Neurology

Cite this

Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline. / Hardies, Katia; Cai, Yiying; Jardel, Claude; Jansen, Anna C.; Cao, Mian; May, Patrick; Djémié, Tania; Hachon Le Camus, Caroline; Keymolen, Kathelijn; Deconinck, Tine; Bhambhani, Vikas; Long, Catherine; Sajan, Samin A.; Helbig, Katherine L.; Suls, Arvid; Balling, Rudi; Helbig, Ingo; De Jonghe, Peter; Depienne, Christel; De Camilli, Pietro; Weckhuysen, Sarah; Zara, Federico; Striano, Pasquale.

In: Brain, Vol. 139, No. 9, 01.09.2016, p. 2420-2430.

Research output: Contribution to journalArticle

Hardies, K, Cai, Y, Jardel, C, Jansen, AC, Cao, M, May, P, Djémié, T, Hachon Le Camus, C, Keymolen, K, Deconinck, T, Bhambhani, V, Long, C, Sajan, SA, Helbig, KL, Suls, A, Balling, R, Helbig, I, De Jonghe, P, Depienne, C, De Camilli, P, Weckhuysen, S, Zara, F & Striano, P 2016, 'Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline', Brain, vol. 139, no. 9, pp. 2420-2430. https://doi.org/10.1093/brain/aww180
Hardies, Katia ; Cai, Yiying ; Jardel, Claude ; Jansen, Anna C. ; Cao, Mian ; May, Patrick ; Djémié, Tania ; Hachon Le Camus, Caroline ; Keymolen, Kathelijn ; Deconinck, Tine ; Bhambhani, Vikas ; Long, Catherine ; Sajan, Samin A. ; Helbig, Katherine L. ; Suls, Arvid ; Balling, Rudi ; Helbig, Ingo ; De Jonghe, Peter ; Depienne, Christel ; De Camilli, Pietro ; Weckhuysen, Sarah ; Zara, Federico ; Striano, Pasquale. / Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline. In: Brain. 2016 ; Vol. 139, No. 9. pp. 2420-2430.
@article{0993de52ac1b436aa3a20c063c5d789b,
title = "Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline",
abstract = "SYNJ1 encodes a polyphosphoinositide phosphatase, synaptojanin 1, which contains two consecutive phosphatase domains and plays a prominent role in synaptic vesicle dynamics. Autosomal recessive inherited variants in SYNJ1 have previously been associated with two different neurological diseases: a recurrent homozygous missense variant (p.Arg258Gln) that abolishes Sac1 phosphatase activity was identified in three independent families with early onset parkinsonism, whereas a homozygous nonsense variant (p.Arg136∗) causing a severe decrease of mRNA transcript was found in a single patient with intractable epilepsy and tau pathology. We performed whole exome or genome sequencing in three independent sib pairs with early onset refractory seizures and progressive neurological decline, and identified novel segregating recessive SYNJ1 defects. A homozygous missense variant resulting in an amino acid substitution (p.Tyr888Cys) was found to impair, but not abolish, the dual phosphatase activity of SYNJ1, whereas three premature stop variants (homozygote p.Trp843∗ and compound heterozygote p.Gln647Argfs∗6/p.Ser1122Thrfs∗3) almost completely abolished mRNA transcript production. A genetic follow-up screening in a large cohort of 543 patients with a wide phenotypical range of epilepsies and intellectual disability revealed no additional pathogenic variants, showing that SYNJ1 deficiency is rare and probably linked to a specific phenotype. While variants leading to early onset parkinsonism selectively abolish Sac1 function, our results provide evidence that a critical reduction of the dual phosphatase activity of SYNJ1 underlies a severe disorder with neonatal refractory epilepsy and a neurodegenerative disease course. These findings further expand the clinical spectrum of synaptic dysregulation in patients with severe epilepsy, and emphasize the importance of this biological pathway in seizure pathophysiology.",
keywords = "early onset epilepsy, neurodegenerative disorder, recessive disorder, SYNJ1, SYNJ1 dual phosphatase activity",
author = "Katia Hardies and Yiying Cai and Claude Jardel and Jansen, {Anna C.} and Mian Cao and Patrick May and Tania Dj{\'e}mi{\'e} and {Hachon Le Camus}, Caroline and Kathelijn Keymolen and Tine Deconinck and Vikas Bhambhani and Catherine Long and Sajan, {Samin A.} and Helbig, {Katherine L.} and Arvid Suls and Rudi Balling and Ingo Helbig and {De Jonghe}, Peter and Christel Depienne and {De Camilli}, Pietro and Sarah Weckhuysen and Federico Zara and Pasquale Striano",
year = "2016",
month = "9",
day = "1",
doi = "10.1093/brain/aww180",
language = "English",
volume = "139",
pages = "2420--2430",
journal = "Brain",
issn = "0006-8950",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline

AU - Hardies, Katia

AU - Cai, Yiying

AU - Jardel, Claude

AU - Jansen, Anna C.

AU - Cao, Mian

AU - May, Patrick

AU - Djémié, Tania

AU - Hachon Le Camus, Caroline

AU - Keymolen, Kathelijn

AU - Deconinck, Tine

AU - Bhambhani, Vikas

AU - Long, Catherine

AU - Sajan, Samin A.

AU - Helbig, Katherine L.

AU - Suls, Arvid

AU - Balling, Rudi

AU - Helbig, Ingo

AU - De Jonghe, Peter

AU - Depienne, Christel

AU - De Camilli, Pietro

AU - Weckhuysen, Sarah

AU - Zara, Federico

AU - Striano, Pasquale

PY - 2016/9/1

Y1 - 2016/9/1

N2 - SYNJ1 encodes a polyphosphoinositide phosphatase, synaptojanin 1, which contains two consecutive phosphatase domains and plays a prominent role in synaptic vesicle dynamics. Autosomal recessive inherited variants in SYNJ1 have previously been associated with two different neurological diseases: a recurrent homozygous missense variant (p.Arg258Gln) that abolishes Sac1 phosphatase activity was identified in three independent families with early onset parkinsonism, whereas a homozygous nonsense variant (p.Arg136∗) causing a severe decrease of mRNA transcript was found in a single patient with intractable epilepsy and tau pathology. We performed whole exome or genome sequencing in three independent sib pairs with early onset refractory seizures and progressive neurological decline, and identified novel segregating recessive SYNJ1 defects. A homozygous missense variant resulting in an amino acid substitution (p.Tyr888Cys) was found to impair, but not abolish, the dual phosphatase activity of SYNJ1, whereas three premature stop variants (homozygote p.Trp843∗ and compound heterozygote p.Gln647Argfs∗6/p.Ser1122Thrfs∗3) almost completely abolished mRNA transcript production. A genetic follow-up screening in a large cohort of 543 patients with a wide phenotypical range of epilepsies and intellectual disability revealed no additional pathogenic variants, showing that SYNJ1 deficiency is rare and probably linked to a specific phenotype. While variants leading to early onset parkinsonism selectively abolish Sac1 function, our results provide evidence that a critical reduction of the dual phosphatase activity of SYNJ1 underlies a severe disorder with neonatal refractory epilepsy and a neurodegenerative disease course. These findings further expand the clinical spectrum of synaptic dysregulation in patients with severe epilepsy, and emphasize the importance of this biological pathway in seizure pathophysiology.

AB - SYNJ1 encodes a polyphosphoinositide phosphatase, synaptojanin 1, which contains two consecutive phosphatase domains and plays a prominent role in synaptic vesicle dynamics. Autosomal recessive inherited variants in SYNJ1 have previously been associated with two different neurological diseases: a recurrent homozygous missense variant (p.Arg258Gln) that abolishes Sac1 phosphatase activity was identified in three independent families with early onset parkinsonism, whereas a homozygous nonsense variant (p.Arg136∗) causing a severe decrease of mRNA transcript was found in a single patient with intractable epilepsy and tau pathology. We performed whole exome or genome sequencing in three independent sib pairs with early onset refractory seizures and progressive neurological decline, and identified novel segregating recessive SYNJ1 defects. A homozygous missense variant resulting in an amino acid substitution (p.Tyr888Cys) was found to impair, but not abolish, the dual phosphatase activity of SYNJ1, whereas three premature stop variants (homozygote p.Trp843∗ and compound heterozygote p.Gln647Argfs∗6/p.Ser1122Thrfs∗3) almost completely abolished mRNA transcript production. A genetic follow-up screening in a large cohort of 543 patients with a wide phenotypical range of epilepsies and intellectual disability revealed no additional pathogenic variants, showing that SYNJ1 deficiency is rare and probably linked to a specific phenotype. While variants leading to early onset parkinsonism selectively abolish Sac1 function, our results provide evidence that a critical reduction of the dual phosphatase activity of SYNJ1 underlies a severe disorder with neonatal refractory epilepsy and a neurodegenerative disease course. These findings further expand the clinical spectrum of synaptic dysregulation in patients with severe epilepsy, and emphasize the importance of this biological pathway in seizure pathophysiology.

KW - early onset epilepsy

KW - neurodegenerative disorder

KW - recessive disorder

KW - SYNJ1

KW - SYNJ1 dual phosphatase activity

UR - http://www.scopus.com/inward/record.url?scp=84994817804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994817804&partnerID=8YFLogxK

U2 - 10.1093/brain/aww180

DO - 10.1093/brain/aww180

M3 - Article

VL - 139

SP - 2420

EP - 2430

JO - Brain

JF - Brain

SN - 0006-8950

IS - 9

ER -